Flare Capital Partners hired Parth Desai as a senior associate. Desai joined Flare Capital from the investment team at New York-Presbyterian Ventures. Desai also worked at Deloitte Consulting. He began his career as a health policy analyst for the Massachusetts House of Representatives, where he led development of legislation reforming oversight of the pharmaceutical industry in the state.
Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the addition of healthcare technology investor and experienced policy professional Parth Desai as a Senior Associate.
“Parth has dedicated his academic work and professional career to the transformation of the business of healthcare and is an incredible addition to our team,” said Bill Geary, co-founder and partner, Flare Capital.
Desai has been an advocate for profound healthcare innovation throughout his career. He joins Flare Capital from the investment team at New York-Presbyterian Ventures, where he spent time identifying innovations that have the potential to improve the quality and experience of care. Desai also spent several years at Deloitte Consulting helping hospital and health plan executives reinvent their business models and invest in capabilities to succeed in risk-bearing arrangements.
“We are very excited to have Parth on board and are confident that he will be critical to the success of our portfolio companies given his depth of understanding as to where the current healthcare industry is heading,” added Michael Greeley, co-founder and partner, Flare Capital.
Desai began his career as a Health Policy Analyst for the Massachusetts House of Representatives, where he led development of legislation reforming oversight of the pharmaceutical industry in Massachusetts and was an appointee to the Health and Human Services Committee of the National Conference of State Legislatures. Desai often speaks on panels and writes about the topics of healthcare innovation and selling into hospital systems. He is also an active mentor to a number of healthcare start-ups.
“Parth has been an extremely valuable and committed partner to our growth and I think he will be a great addition to the Flare Capital team as well as an excellent resource for entrepreneurs in the healthcare industry. I look forward to continuing to work with him in his new role,” added Harjinder Sandhu, CEO of Saykara.
“This is a terrific opportunity for Parth and provides him a platform to guide exciting start-ups through the complexity of the healthcare industry, public policy and scaling great young companies. Given the dynamic nature of today’s healthcare landscape, his unique background serves as an excellent resource for entrepreneurs. Flare Capital is a natural fit and the opportunities are boundless,” observed Jeffrey Sanchez, a Menschel Fellow at the Harvard T.H. Chan School of Public Health and former House Ways & Means Chairman for the Massachusetts House of Representatives.
Desai earned his Master of Arts in Clinical Medicine and a Master of Public Health in Health Management and Policy, both from Boston University. Additionally, he graduated from Boston College with a BS in Biology.
About Flare Capital Partners
Flare Capital is a team of proven healthcare technology venture capital investors and senior operating executives known for their unparalleled strategic industry resources, insight and total commitment to the success of its entrepreneurs. Flare Capital raised one of the industry’s largest dedicated venture capital funds focused exclusively on early stage opportunities in healthcare technology innovation and is privileged to closely partner with founders and management. Selected investments include Aetion, Aspen RxHealth, Bright Health, Circulation (acquired by LogistiCare), ClearDATA, Curisium, HealthReveal, HealthVerity, Iora Health, Somatus, Valence Health (acquired by Evolent Health), VisitPay and Welltok.
Learn more at www.flarecapital.com and follow the firm on Twitter @FlareCapital.